These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29031077)

  • 1. 4-Quinolone hybrids and their antibacterial activities.
    Hu YQ; Zhang S; Xu Z; Lv ZS; Liu ML; Feng LS
    Eur J Med Chem; 2017 Dec; 141():335-345. PubMed ID: 29031077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Quinolone derivatives and their activities against Gram positive pathogens.
    Zhang GF; Zhang S; Pan B; Liu X; Feng LS
    Eur J Med Chem; 2018 Jan; 143():710-723. PubMed ID: 29220792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in quinolone hybrids with potential antibacterial activity against drug-resistant bacteria.
    Jun W; Yumin S; Heng Y
    Future Med Chem; 2023 Mar; 15(6):555-578. PubMed ID: 37102377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents.
    Zhang J; Wang S; Ba Y; Xu Z
    Eur J Med Chem; 2019 Jul; 174():1-8. PubMed ID: 31015103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments of quinolone-based derivatives and their activities against Escherichia coli.
    Gao F; Wang P; Yang H; Miao Q; Ma L; Lu G
    Eur J Med Chem; 2018 Sep; 157():1223-1248. PubMed ID: 30193220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin derivatives and their antibacterial activities.
    Zhang GF; Liu X; Zhang S; Pan B; Liu ML
    Eur J Med Chem; 2018 Feb; 146():599-612. PubMed ID: 29407984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current scenario of tetrazole hybrids for antibacterial activity.
    Gao F; Xiao J; Huang G
    Eur J Med Chem; 2019 Dec; 184():111744. PubMed ID: 31605865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens.
    Gao J; Hou H; Gao F
    Eur J Med Chem; 2023 Feb; 247():115026. PubMed ID: 36577217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity study of 1,2,4-triazole derivatives.
    Gao F; Wang T; Xiao J; Huang G
    Eur J Med Chem; 2019 Jul; 173():274-281. PubMed ID: 31009913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of first ever 4-quinolone-3-carboxylic acid-appended spirooxindole-pyrrolidine derivatives and their biological applications.
    Arasakumar T; Mathusalini S; Ata A; Shankar R; Gopalan S; Lakshmi K; Sakthivel P; Mohan PS
    Mol Divers; 2017 Feb; 21(1):37-52. PubMed ID: 27670880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CH
    Dai H; Hu Y; Zhang Y; Zhu Q; Xu T; Cui P; Fan R; He Q
    Eur J Med Chem; 2024 May; 271():116399. PubMed ID: 38640868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent updates of fluoroquinolones as antibacterial agents.
    Ezelarab HAA; Abbas SH; Hassan HA; Abuo-Rahma GEA
    Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800141. PubMed ID: 30048015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent.
    Wang XD; Wei W; Wang PF; Tang YT; Deng RC; Li B; Zhou SS; Zhang JW; Zhang L; Xiao ZP; Ouyang H; Zhu HL
    Bioorg Med Chem; 2014 Jul; 22(14):3620-8. PubMed ID: 24882676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
    Zhang B
    Eur J Med Chem; 2019 Apr; 168():357-372. PubMed ID: 30826511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isatin derivatives and their anti-bacterial activities.
    Guo H
    Eur J Med Chem; 2019 Feb; 164():678-688. PubMed ID: 30654239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of halogenated 4-quinolones and evaluation of their antiplasmodial activity.
    Vandekerckhove S; Desmet T; Tran HG; de Kock C; Smith PJ; Chibale K; D'hooghe M
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1214-7. PubMed ID: 24468411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
    Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
    J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinoline and quinolone dimers and their biological activities: An overview.
    Chu XM; Wang C; Liu W; Liang LL; Gong KK; Zhao CY; Sun KL
    Eur J Med Chem; 2019 Jan; 161():101-117. PubMed ID: 30343191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, structure-activity relationship and antibacterial activity series of novel imidazo fused quinolone carboxamides.
    Reddy GV; Kanth SR; Maitraie D; Narsaiah B; Rao PS; Kishore KH; Murthy US; Ravi B; Kumar BA; Parthasarathy T
    Eur J Med Chem; 2009 Apr; 44(4):1570-8. PubMed ID: 18775585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.